MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-KR-03-0008931
Bioplus Life Sciences Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹90.96 Cr
▲ 6% YoY
Net profit · FY 2022
₹13.44 Cr
Net margin 14.8%
EBITDA · FY 2022
₹20.32 Cr
EBITDA margin 22.3%
Authorised capital
₹36.35 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹85.4 Cr
Satisfied ₹20.6 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
276
Provident fund records
About Bioplus Life Sciences Private Limited
Data last updated:
Bioplus Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2004PTC033578. Its GSTIN is 29AACCB3621R1ZB (Karnataka).
The company has an authorised share capital of ₹36.35 Cr and a paid-up capital of ₹3 Cr. It was formerly known as Bioplus Pharmaceutical Pvt Ltd. It is led by directors including Sundeep Aurora and Sunjeev Aurora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S.No.10 – 1A Hoodi Village Krishnarajapuram Hobli Bangalore, Karnataka, India – 560048.
As per the financials filed for FY 2022, the company reported a revenue of ₹90.96 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹13.44 Cr (net margin 14.8%) and EBITDA of ₹20.32 Cr (EBITDA margin 22.3%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 6% over five years.
The company has about 276 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 2 brands: Bioplus Life Sciences and Bioplus Life Sciences. As per MCA filings, the company has open charges of ₹85.4 Cr and satisfied charges of ₹20.6 Cr on record. Court records list 25 cases involving the company, including 15 filed by the company and 10 filed against it. The company has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹125.99 Cr; the latest was in November 2019. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 956 overdue payments to 131 micro and small suppliers.
Bioplus Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-KR-03-0008931). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bioplus.in.
Company details
CIN U24232KA2004PTC033578
Registration Number 033578
Incorporation Date 19 March 2004
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-KR-03-0008931
Recognitions & Rankings of Bioplus Life Sciences
Contact details
Bioplus Life Sciences Private Limited's registered office is in Bangalore, Karnataka. Its website is bioplus.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS.No.10 – 1A Hoodi Village Krishnarajapuram Hobli Bangalore, Karnataka, India – 560048
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bioplus Life Sciences Private Limited, buy the company report.
Comprehensive company report
Bioplus Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bioplus Life Sciences operates two associated brands: Bioplus Life Sciences and Bioplus Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biopharmaceutical company focused on drug discovery for myopia and R&D in healthcare. | biopluslifesciences.com | |
| Novel therapeutics and pharmaceutical products are developed and manufactured. | bioplus.in |
Financials of Bioplus Life Sciences Private Limited
FY 2025 filings availableBioplus Life Sciences Private Limited reported revenue of ₹90.96 Cr (up 6% YoY) for FY 2022.
Revenue · FY 2022
₹90.96 Cr ▲ 6%
Net profit · FY 2022
₹13.44 Cr margin 14.8%
EBITDA · FY 2022
₹20.32 Cr margin 22.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 18%
5 years · compounded
▲ 6%
EBITDA CAGR growth
3 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 6% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹90.96 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.3% | ||||
| Net Profit Margin | 14.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioplus Life Sciences Private Limited, buy the company report.
Board of directors of Bioplus Life Sciences Private Limited
Bioplus Life Sciences has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neha Aurora Also directs: Alphaceutics Innovations Private Limited, Biosys Biopharma Private Limited, Va Foodcom Private Limited and 1 more | Additional Director | 29 Oct 2025 | 1 Years 0 Months | Current |
| Sundeep Aurora | Director | 12 May 2008 | 18 Years 5 Months | Current |
| Sunjeev Aurora Also directs: Bioplus Healthcare Private Limited | Director | 12 May 2008 | 18 Years 5 Months | Current |
| Rhea Ishani Aurora | Additional Director | 29 Oct 2025 | 1 Years 0 Months | Current |
Auditor
Bioplus Life Sciences Private Limited is audited by MS KA & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MS KA & Associates | FY 2022 | 105047W |
Shareholding
The shareholding of Bioplus Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bioplus Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹85.4 Cr
Satisfied charges
₹20.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Apr 2025 | 101084636 | Others | ₹85.4 Cr | Open | |
| 09 Nov 2005 | 80033583 | Canara Bank | ₹20.6 Cr | Satisfied |
To see the full charge records of Bioplus Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Bioplus Life Sciences Private Limited has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹125.99 Cr; the latest was in November 2019.
Total deals
6
Secondary share transfers
5
Funding round
1
Disclosed funding
₹125.99 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2019 | Secondary share transfer | Undisclosed | Seller: AIF Capital |
| Jun 2008 | Funding round | ₹125.99 Cr | Investors: AIF Capital |
| May 2008 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Neha Trust, an individual |
| May 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Sushma Trust |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Sushma Trust |
To see the full deal history of Bioplus Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bioplus Life Sciences Private Limited has 25 court cases on record: 15 filed by Bioplus Life Sciences, 10 filed against it. All cases are disposed.
Total cases
25
Filed by the company
15
Filed against the company
10
Disposed
25
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 20 | 9 | 0 |
| District courts | 4 | 1 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0104-Labour Matters : Matters relating to wages, bonus, ad-hoc, casual daily wages & their regularisation) | Filed by the company against North Karnataka Durgs and Pharmaceutical Manufacturers Welfare Association Represented by Its Hon.Secretary C/O Nandu Chemicals Pvt.Ltd., N-12, Industrial Estate Gokul Road Hubli-580 030 , , Karnataka and 19 others | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against M/S Pharmed Medicare Pvt Ltd and 1 other | Disposed |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed by the company against an individual | Disposed |
| District court, BENGALURU, Karnataka | Motor accident claim | Filed against the company by an individual | Disposed |
| High Court of Karnataka | Appeal | Filed against the company | Disposed |
To see the full case history of Bioplus Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Bioplus Life Sciences Private Limited was last rated by Icra on 22 Apr 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 22 Apr 2021 |
To see the full credit ratings and regulatory alerts of Bioplus Life Sciences Private Limited, buy the company report.
MSME payment delays
Bioplus Life Sciences Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 956 overdue payments to 131 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 131)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Vsix Analytical Labs Private Limited | |||
| Zener Systems Private Limited | |||
| Vivek Polymer (India) | |||
| Pharmintech Turnkey Solutions Private Limited |
To see the full MSME payment records of Bioplus Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Bioplus Life Sciences has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Bioplus Healthcare Private Limited | U24232KA2005PTC036131 | |
| VB Medicare Private Limited | U24239TG2004PTC042696 |
To see the full group structure of Bioplus Life Sciences Private Limited, buy the company report.
Employees & EPFO
Bioplus Life Sciences Private Limited has a workforce of 276 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
276
Active EPFO establishments
1
Employee growth
8.24%
GST
Bioplus Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCB3621R1ZB | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bioplus Life Sciences Private Limited, buy the company report.
Recent activity
Bioplus Life Sciences Private Limited has 14 board changes on record since 2008: 4 appointments and 10 cessations. The latest: Neha Aurora was appointed as Additional Director on 29 Oct 2025.
Appointed
Neha Aurora was appointed as Additional Director.
Appointed
Rhea Ishani Aurora was appointed as Additional Director.
AGM
Bioplus Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Neha Aurora ceased to be Additional Director.
Charges
A charge registered on 09 Nov 2005 via Charge ID 80033583 with Canara Bank was fully satisfied on 12 Jun 2025.
Charges
A charge with Others amounted to Rs. 85.40 Cr with Charge ID 101084636 was registered on 15 Apr 2025.
Filing
Bioplus Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Ashish Ahluwalia ceased to be Nominee Director.
Ceased
Ajay Lal ceased to be Nominee Director.
Ceased
Krishan Kumar Aurora ceased to be Director.
Charges
A charge with Canara Bank of Rs. 20.60 Cr registered on 09 Nov 2005 with Charge ID 80033583 was modified on 24 Oct 2011.
Ceased
Barry Clare ceased to be Director.
9 earlier events are in the company report.
Frequently asked questions
Bioplus Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 March 2004 (22+ years old) and is registered under CIN U24232KA2004PTC033578.
Bioplus Life Sciences has 4 current directors:
- Neha Aurora - Additional Director
- Sundeep Aurora - Director
- Sunjeev Aurora - Director
- Rhea Ishani Aurora - Additional Director
The latest financial statements of Bioplus Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bioplus Life Sciences is 29AACCB3621R1ZB, registered in Karnataka.
The CIN (Corporate Identification Number) of Bioplus Life Sciences is U24232KA2004PTC033578. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioplus Life Sciences has 25 court cases on record: 15 filed by the company and 10 filed against it. Most are in the high courts.
Bioplus Life Sciences was incorporated on 19 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Bangalore.
Bioplus Life Sciences has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹125.99 Cr; the latest was in November 2019.
Neha Aurora was appointed as Additional Director on 29 Oct 2025. Rhea Ishani Aurora was appointed as Additional Director on 29 Oct 2025. Neha Aurora ceased to be Additional Director on 30 Sep 2025. Bioplus Life Sciences has 14 board changes on record in total.
Yes, Bioplus Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-KR-03-0008931).
Bioplus Life Sciences has 12 MSME Form 1 returns on record between 2019 and 2024, listing 956 overdue payments to 131 micro and small suppliers. The latest return was filed on 30 Apr 2024.